EPG Online Twitter
EPG Online Blog
Disease Knowledge
Drug Updates
- Fostair 100/6 inhalation solution
- Epanutin capsules 25, 50 and 100mg
- Eprex 2000, 4000 and 10000 IU/ml solution for injection in pre-filled syringe
- FemSeven Conti
- Epanutin 300mg hard capsules
- Bedranol 80mg SR Capsules
- Bedranol 160mg SR Capsules
- Betim 10mg Tablets
- Carbo-Dome Cream
- Bisoprolol 2.5mg/5mg/10mg film coated tablet
- Phenergan Injection
- Rivotril 0.5 mg and 2 mgTablets
- Rivotril Ampoules
- RELPAX 20mg and 40mg Film-Coated Tablets
- Witch Doctor ® 81.5%w/w Gel
- Levetiracetam Actavis 1,000 mg film-coated tablets
- Levetiracetam Actavis 250 mg film-coated tablets
- Levetiracetam Actavis 500 mg film-coated tablets
- Levetiracetam Actavis 750 mg film-coated tablets
- Lidocaine Hydrochloride Injection BP 1% w/v plastic ampoules
- Lidocaine Hydrochloride Injection BP 2.0% w/v
- Omeprazole 10mg Capsules
- Omeprazole 20mg Capsules
- Panadol Extra Advance 500 mg/65 mg Tablets
- Allopurinol Tablets BP 300mg
- Allopurinol Tablets BP 100mg
- Anadin Ultra Double Strength 400mg Capsules/Anadin LiquiFast 400mg Capsules
- Calcipotriol Scalp Solution
- Bupivacaine Hydrochloride Injection BP 0.5% w/v.
- Lescol (fluvastatin* sodium) 20 mg and 40 mg capsules
- Meropenem 1 g Powder for Solution for Injection or Infusion
- VALTREX Tablets 250mg
- Vesicare 5mg & 10mg film-coated tablets
- Zomig 5mg Nasal Spray
- Water for Injections
- Tizanidine 2mg Tablets
- NovoRapid 100 U/ml in a vial, NovoRapid Penfill 100 U/ml, NovoRapid FlexPen 100 U/ml, NovoRapid FlexTouch 100 U/ml
- Orfadin 10 mg hard capsules
- Orfadin 2 mg hard capsules
- Natecal D3 Chewable Tablets
Please register to access disease diagnosis, patient management, physician tools.
By viewing the content of this web page you are both confirming your status as a healthcare professional and agreeing to our terms of use.
Dopamine agonists.
Generic
Tablets.
Tablets, bromocriptine (as mesylate) 2.5 mg . Available from Hillcross, Norton.
Prevention or suppression of puerperal lactation for medical reasons. Hyperprolactinaemia. Cyclical benign breast disease, pronounced mastalgia.
Prevention of lactation: initially 2 .5 mg on day of delivery, then 2.5 mg twice daily with meals for 14 days.
Suppression of lactation: initially 2 .5 mg on first day increasing after two to three days to 2.5 mg twice daily with meals for 14 days.
Hyperprolactinaemia: initially 1 - 1.25 mg at night. Titrate gradually at 2 to 3 day intervals to 7 .5 mg daily in divided doses with meals; max. 30 mg daily. Benign breast disease, mastalgia, initially, 1 - 1.25 mg at night. Titrate gradually to 2.5 mg twice daily with meals.
Toxaemia of pregnancy, puerperal and postpartum hypertension. and postpartum hypertension. Hypersensitivity to ergot alkaloids.
History of psychotic or severe cardiovascular disorders. Monitor BP, if hypertension, severe headache or signs of CNS toxicity develop withdraw immediately.
May induce ovulation; nonhormonal contraceptive measures should be taken if patient does not wish to conceive. Withdraw if conception occurs. Perform regular gynaecological assessment. Consider discontinuation in patients with unexplained pleuro- pulmonary signs or symptoms.
Alcohol, erythromycin, metoclopramide, drugs affecting BP.
Nausea, postural hypotension, dizziness, headache, vomiting, constipation, digital vasospasm, drowsiness, confusion, psychomotor excitation, hallucinations, dyskinesia, dry mouth, leg cramps. Retroperitoneal fibrosis on long term therapy (discontinue if occurs).
(POM)
14 April 2009





